Enveric Biosciences (ENVB) Interest Coverage Ratio (QoQ) (2013 - 2023)
Enveric Biosciences (ENVB) Interest Coverage Ratio (QoQ) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -386.74% |
| Dec 31, 2022 | -394.29% |
| Sep 30, 2022 | -160.66% |
| Jun 30, 2022 | -507.95% |
| Mar 31, 2022 | 88.35% |
| Dec 31, 2021 | -206,495.43% |
| Sep 30, 2021 | 88.20% |
| Jun 30, 2021 | -283.70% |
| Mar 31, 2021 | 82.76% |
| Dec 31, 2020 | -11,071.20% |
| Sep 30, 2020 | 34.25% |
| Jun 30, 2020 | 73.72% |
| Mar 31, 2020 | 26.47% |
| Dec 31, 2019 | 29.28% |
| Sep 30, 2019 | -31.97% |
| Jun 30, 2019 | 48.56% |
| Mar 31, 2019 | 87.77% |
| Dec 31, 2018 | -331.16% |
| Sep 30, 2018 | 641.75% |
| Jun 30, 2018 | 8.63% |